Two-coloured magnetic-laser therapy in sarcoidosis

H. L. Baradzina, N. V. Ponachevnaya (Minsk, Belarus)

Source: Annual Congress 2005 - The many faces of sarcoidosis I
Session: The many faces of sarcoidosis I
Session type: Thematic Poster Session
Number: 610
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. L. Baradzina, N. V. Ponachevnaya (Minsk, Belarus). Two-coloured magnetic-laser therapy in sarcoidosis. Eur Respir J 2005; 26: Suppl. 49, 610

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High-doses glucocorticosteroid treatment in sarcoidosis patients
Source: Eur Respir J 2007; 30: Suppl. 51, 118s
Year: 2007

Safety of corticosteroid therapy in patients with pulmonary sarcoidosis
Source: International Congress 2017 – The many faces of sarcoidosis
Year: 2017


Multicolored magnetic-laser therapy in asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 510s
Year: 2004

Corticosteroid treatment in sarcoidosis
Source: Eur Respir J 2006; 28: 627-636
Year: 2006



Rituximab in the treatment of refractory pulmonary sarcoidosis
Source: Eur Respir J 2014; 43: 1525-1528
Year: 2014


Efficacy of traditional and combined therapy in patients with sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 234s
Year: 2003

Combination of pentoxifylline and steroids in sarcoidosis treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 269s
Year: 2005

Markers of resistance to corticosteroids therapy in patients with pulmonary sarcoidosis
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020


Glucocorticosteroid treatment in sarcoidosis: comparison of regimens
Source: Eur Respir J 2003; 22: Suppl. 45, 234s
Year: 2003

Long-term treatment with infliximab in patients with sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011

Infliximab: An effective rescue therapy in refractory extra-pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

The clinico-immunological evaluation of the ribomunyl therapy in complex treatment of COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 674s
Year: 2006

Azathioprine and low-dose prednisone in chronic pulmonary sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 268s
Year: 2005

Combined immunosuppressive therapy including anti-TNFα in a treatment of severe paediatric sarcoidosis – a case report
Source: Eur Respir J 2006; 28: Suppl. 50, 829s
Year: 2006

Pulse therapy of corticosteroids in idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010


Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis
Source: Eur Respir J 2014; 43: 602-609
Year: 2013



Established and experimental medical therapy of pulmonary sarcoidosis
Source: Eur Respir J 2013; 41: 1424-1438
Year: 2013



Clinical benefits of ambroxol and millimeter wave therapy combination in sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 669s
Year: 2004

Etiology and etiotropic therapy of angiogenic sepsis
Source: Eur Respir J 2003; 22: Suppl. 45, 452s
Year: 2003

Standard therapy for sarcoidosis
Source: Annual Congress 2005 - Biological agents in the therapy of sarcoidosis
Year: 2005